11.8
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present betwee…
MicroRNA, miRNA, is a type of small, regulatory RNA that does not code for protein. Instead it regulates gene expression by inhibiting the translation of messenger RNA, mRNA, into protein.
MicroRNAs are around 22 nucleotides long and are produced through the cleavage of a double-stranded RNA precursor molecule with a hairpin turn. The two strands separate, and one becomes the mature miRNA, which forms a complex with a group of proteins called RISC, RNA-induced silencing complex.
This complex binds to mRNA through complimentary base pairing between the miRNA and specific sequences in the mRNA, typically in the 3-prime untranslated region. This pairing is usually not perfect, but it is enough to inhibit translation, either through cleavage and destruction of the mRNA or by interfering with the translation process itself.
Either way, gene expression is silenced, which is an important type of post-transcriptional regulation. In fact, dysregulation of miRNA is correlated with potentially deadly diseases, such as cancer and heart disease.
View the full transcript and gain access to JoVE Core videos
Q1: What are microRNAs and what is their primary function in cells?
MicroRNAs are small non-coding RNA molecules, typically 18-25 nucleotides long, that regulate gene expression post-transcriptionally. They bind to complementary sequences on target messenger RNAs, leading to translational repression or mRNA degradation. This mechanism allows cells to fine-tune protein production and control developmental and physiological processes.
Q2: How do microRNAs differ from other small regulatory RNAs like siRNAs?
MicroRNAs are endogenously encoded and processed from longer precursor transcripts within the genome, whereas small interfering RNAs post transcription gene silencing are typically exogenous or derived from long double-stranded RNA. Both regulate gene expression through RNA interference pathways, but microRNAs generally have imperfect complementarity to targets, allowing one microRNA to regulate multiple genes.
Q3: What is the biogenesis pathway for microRNAs from their initial transcription to mature form?
MicroRNA biogenesis begins with transcription of primary microRNA transcripts in the nucleus. These are processed by the enzyme Drosha into precursor microRNAs, which are exported to the cytoplasm. There, Dicer cleaves the precursor into mature microRNA duplexes. One strand is incorporated into the RNA-induced silencing complex for target recognition and regulation.
Q4: How do microRNAs recognize and bind to their target messenger RNAs?
MicroRNAs recognize target mRNAs through base-pairing interactions, primarily between the microRNA seed region and complementary sequences in the 3' untranslated region of target transcripts. Perfect or near-perfect complementarity typically triggers mRNA cleavage and degradation, while partial complementarity usually causes translational repression without mRNA destruction, allowing flexible regulation.
Q5: What are the consequences of microRNA dysregulation in disease?
Aberrant microRNA expression is implicated in cancer, cardiovascular disease, and neurological disorders. Oncogenic microRNAs can suppress tumor suppressors, while loss of tumor-suppressive microRNAs allows uncontrolled cell proliferation. Dysregulated microRNAs also affect mRNA stability and gene expression patterns, disrupting normal cellular homeostasis and contributing to disease pathogenesis and progression.
Q6: Can microRNAs be used as biomarkers or therapeutic targets?
Yes, microRNA expression profiles can serve as diagnostic and prognostic biomarkers for various diseases, including cancer. Therapeutically, microRNA inhibitors or mimics can modulate disease-associated microRNA levels. Antagomirs block pathogenic microRNAs, while synthetic microRNA replacements restore lost tumor-suppressive functions, offering promising avenues for precision medicine and personalized treatment strategies.
Q7: How do microRNAs coordinate with other regulatory mechanisms to control gene expression?
MicroRNAs work synergistically with transcriptional regulators, RNA-binding proteins, and other post-transcriptional mechanisms to fine-tune gene expression. They can target long non-coding rnas chromatin modification pathways, affecting epigenetic regulation. This multilayered control ensures precise spatiotemporal expression of genes critical for development, differentiation, and cellular responses to environmental signals.